The rating affirmation is based on a number of factors, including FCGH’s strong market position, strengthened balance sheet and operating cash flow growth.
The outlook is stable, reflecting Moody’s Investors Service’s expectation that FCGH will maintain a healthy balance sheet and continue to generate operating performance in line with its historical performance.
More articles on healthcare finance:
How Obama’s 2017 budget takes on surprise medical billing
Morgan Stanley buys 131,022 shares of athenahealth
ACP releases plan to address soaring drug prices
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
